For almost two-thirds of his life, Nick Jonas has lived with a chronic condition — type 1 diabetes. The Jonas Brothers-famed ...

Weight-loss jabs, such as Ozempic and Wegovy, have revolutionised the way we treat obesity in humans, and scientists now want ...

With India facing over 101 million cases of diabetes and rising obesity levels, the drug could play a significant role in ...

The star has previously been very open about her use of weight loss jabs on the programme, and has now dropped four dress ...

The managing director of Novo Nordisk India on Ozempic’s delayed launch in India, leading the fight against diabetes and ...

GLP-1 weight-loss injections are increasingly misused without proper medical guidance in India. Experts warn this trend leads ...

AIIMS Delhi reports metabolic surgery helps many with uncontrolled Type-2 diabetes; 30% stopped meds. Early intervention ...

IRELAND’S first recipient of a simultaneous kidney–pancreas transplant has passed away, with tributes pouring in for the ...

Doctors typically begin patients on 0.25 mg once a week for the first month. After the introductory phase, the dosage ...

Rhythm Pharmaceuticals is rated a Buy, driven by progress in HO, PWS, and oral MC4R agonists. Click here to read my latest ...

The weekly injection was approved by the US Food and Drug Administration in 2017 for people with type 2 diabetes.

VANCOUVER, BC / ACCESS Newswire / December 11, 2025 / LIR Life Sciences Corp. ("LIR" or the "Company") announces that it has filed a provisional patent application intended to cover a needle-free ...